Definitive Contract 75D30122C14642
- Not listed
- This is a $854,668.78 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Texas Medical Branch at Galveston (UTMB) under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract (IDC). The order tasks UTMB with utilizing an established human lung microphysiological system (MPS) to optimize a SARS-CoV-2 infection model and test candidate countermeasures. UTMB has subcontracted portions of this work to...
- This is a $2,636,584 firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The contract was awarded to the University of Texas Medical Branch at Galveston (UTMB) to provide animal model testing of mice for Ebola research under NIAID's Animal Models of Infectious Diseases contract vehicle, which has a ceiling value of $146.3 million. UTMB is a major academic...
- This is a $1,179,674.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the University of Texas Medical Branch at Galveston (UTMB). The contract is for pre-clinical models of infectious diseases research and is part of NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract vehicle, which has a total ceiling value of $2,706,323.34. UTMB, a...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to the University of Texas Medical Branch at Galveston (UTMB) to produce SARS-CoV-2 live virus. The contract, valued at $489,800.00, is for the production of two forms of recombinant SARS-CoV-2 virus - nanoluciferase and firefly luciferase - to support high-throughput screening for COVID-19 treatments. This contract was not set aside...
- This federal contract award was issued by a U.S. government agency to the University of Texas Medical Branch at Galveston (UTMB), a major academic health center that provides a wide range of medical education, research, and patient care services to the federal government. The $424,982.44 firm fixed-price delivery order does not have a set-aside designation. The contract is likely associated with a larger indefinite delivery contract (IDC) that UTMB holds with the National Institute of Allergy...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to the University of Texas Medical Branch at Galveston (UTMB), a state university system, for medical data translation to English related to a COVID-19 seafood workers study. The contract has a potential value of $265,000.00 and a completion date of May 31, 2023. UTMB is a medical institution that provides a wide range of services to the federal...
- This federal contract award, valued at $1,848,326.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Texas Medical Branch at Galveston (UTMB) for the advancement of human lung microphysiological systems to model coronavirus infection and test candidate countermeasures. The award is a delivery order under NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract, a $146.3 million single-award vehicle. UTMB, a...
- The University of Texas Medical Branch at Galveston (UTMB) was awarded a $390,168 Definitive Contract by the Centers for Disease Control and Prevention (CDC) Pittsburgh to conduct work related to Funding Announcement Number FY23 BAA - TOPIC 24. As the prime contractor, UTMB will perform this work in Galveston, Texas from September 1, 2023 through August 31, 2024. The contract pricing type is cost no fee, indicating UTMB will be reimbursed for allowable costs incurred with no potential for fee or...
- This federal contract award is for a delivery order under the "NIAID Animal Models of Infectious Diseases 2010-2017" indefinite delivery contract held by the University of Texas Medical Branch at Galveston (UTMB). The $100,000 order supports unspecified work related to TAS::75 0885::TAS, which was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). As a state-controlled institution of higher learning,...
- This federal contract award is for a task order issued under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The prime contractor is the University of Texas Medical Branch (UTMB) at Galveston, a state government entity and educational institution with extensive experience supporting federal agencies in areas such as infectious disease research, clinical trials, and emergency preparedness. The...
This is a $1,599,820.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Texas Medical Branch at Galveston (UTMB) to provide SARS-CoV-2 animal models for risk assessment of viral pathogenesis. The contract has a period of performance through February 4, 2024 and was awarded on August 5, 2022. UTMB, a state government educational institution, has extensive experience supporting federal agencies through prime and subcontract research, clinical trials, medical training, and public health programs, particularly in the area of infectious disease response. The contract is not associated with a larger indefinite delivery/indefinite quantity (IDIQ) vehicle, and there was no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $0 | 7/12/23 | |
| Not listed | Not listed | $1.6m | 8/4/22 |